Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TECOGEN INC. Director's Dealing 2022

Mar 11, 2022

33623_dirs_2022-03-11_ace17432-8c9f-420f-898b-95b5d521f2f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TECOGEN INC. (TGEN)
CIK: 0001537435
Period of Report: 2022-03-09

Reporting Person: GHONIEM AHMED (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $0.786 2026-05-12 Stock Option (Right to Buy) (12723.0) Direct
Stock Option (Right to Buy) $0.71 2030-07-09 Common Stock (100000.0) Direct
Stock Option (Right to Buy) $1.75 2031-06-08 Common Stock (25000.0) Direct

Footnotes

F1: Vests 25% per year

F2: Vests 20% per year